Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of DuodartTM Versus Watchful Waiting With Step-up Therapy to Tamsulosin in the Management of Treatment naïve Men With Symptomatic BPH

NCT01294592 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01294592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01294592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of DuodartTM Versus Watchful Waiting With Step-up Therapy to Tamsulosin in the Management of Treatment naïve Men With Symptomatic BPH
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
December 22, 2010
Completion date
October 17, 2013
Enrollment
742 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic hyperplasia